MEDNAX, Inc. Announces Resignation of Roger Mack Hinson as President of Pediatrix and Obstetrix Medical Group, Effective as of June 1, 2022
February 25, 2022 at 05:02 pm EST
Share
On February 23, 2022, Mednax, Inc. announced that Roger Mack Hinson, M.D., President of the Company's Pediatrix and Obstetrix Medical Group, would transition from such position, effective as of June 1, 2022 (the “Effective Date”). Dr. Hinson's transition from his role as President of the Company's Pediatrix and Obstetrix Medical Group is a termination without “Cause” pursuant to that certain Amended and Restated Employment Agreement, effective September 27, 2020, by and between Dr. Hinson and a wholly-owned subsidiary of the Company. The Company and Dr. Hinson intend to enter into a consulting agreement pursuant to which Dr. Hinson will continue to serve as an advisor to the Company following the Effective Date.
Pediatrix Medical Group, Inc. is a provider of physician services, including newborn, maternal-fetal, pediatric cardiology and other pediatric subspecialty care. The Companyâs affiliated clinicians provide services to women, babies and children across the continuum of care, both in hospital settings and office-based practices. Its specialties include obstetrics, maternal-fetal medicine and neonatology, complemented by more than 20 pediatric subspecialties, as well as pediatric primary and urgent care clinics. Its national network comprises over 2,620 affiliated physicians, including 1,330 physicians who provide neonatal clinical care, primarily within hospital-based neonatal intensive care units (NICUs), to babies born prematurely or with medical complications. It has over 580 affiliated physicians who provide maternal-fetal and obstetrical medical care to expectant mothers experiencing complicated pregnancies primarily in areas where its affiliated neonatal physicians practice.
PEDIATRIX MEDICAL GROUP, INC. 
